[{"address1": "830 Winter Street", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 999 0232", "website": "https://www.q32bio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti\u0096interleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb \u0096 CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.", "fullTimeEmployees": 42, "companyOfficers": [{"maxAge": 1, "name": "Ms. Jodie Pope Morrison", "age": 48, "title": "CEO & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 852632, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shelia M. Violette Ph.D.", "age": 63, "title": "Co-founder, Chief Scientific Officer & President of Research", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 619930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jason A. Campagna M.D., Ph.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 680927, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lee H. Kalowski M.B.A.", "age": 43, "title": "CFO & President", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Saul W. Fink Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Appugliese J.D.", "title": "Senior VP & Head of People", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maria  Marzilli M.P.H.", "title": "Executive Vice President of Corporate Strategy & Program Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathryn E. Golden M.B.A.", "title": "Head of Chemistry, Manufacturing & Controls", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.85, "open": 1.92, "dayLow": 1.8359, "dayHigh": 1.995, "regularMarketPreviousClose": 1.85, "regularMarketOpen": 1.92, "regularMarketDayLow": 1.8359, "regularMarketDayHigh": 1.995, "payoutRatio": 0.0, "forwardPE": -0.3488806, "volume": 70228, "regularMarketVolume": 70228, "averageVolume": 202180, "averageVolume10days": 166560, "averageDailyVolume10Day": 166560, "bid": 1.82, "ask": 0.0, "bidSize": 1, "askSize": 0, "marketCap": 22809512, "fiftyTwoWeekLow": 1.38, "fiftyTwoWeekHigh": 53.79, "fiftyDayAverage": 2.0463, "twoHundredDayAverage": 22.265425, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -36254460, "profitMargins": 0.0, "floatShares": 3173332, "sharesOutstanding": 12197600, "sharesShort": 868525, "sharesShortPriorMonth": 1008620, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0577, "heldPercentInsiders": 0.08696, "heldPercentInstitutions": 0.79823995, "shortRatio": 4.11, "impliedSharesOutstanding": 12197600, "bookValue": 0.465, "priceToBook": 4.0215054, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -47733000, "trailingEps": -6.58, "forwardEps": -5.36, "lastSplitFactor": "1:18", "lastSplitDate": 1711411200, "enterpriseToEbitda": 0.553, "52WeekChange": -0.93560606, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 1.87, "targetHighPrice": 20.0, "targetLowPrice": 6.0, "targetMeanPrice": 13.66667, "targetMedianPrice": 15.0, "recommendationMean": 2.33333, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 77965000, "totalCashPerShare": 6.392, "ebitda": -65615000, "totalDebt": 18901000, "quickRatio": 4.769, "currentRatio": 4.973, "debtToEquity": 333.057, "returnOnAssets": -0.59278, "grossProfits": -48143000, "freeCashflow": -37946752, "operatingCashflow": -67715000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QTTB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1745623720, "regularMarketTime": 1745611201, "exchange": "NCM", "messageBoardId": "finmb_669405676", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.08108, "regularMarketPrice": 1.87, "shortName": "Q32 Bio Inc.", "longName": "Q32 Bio Inc.", "marketState": "CLOSED", "epsTrailingTwelveMonths": -6.58, "epsForward": -5.36, "fiftyDayAverageChange": -0.17629993, "fiftyDayAverageChangePercent": -0.08615547, "twoHundredDayAverageChange": -20.395424, "twoHundredDayAverageChangePercent": -0.91601324, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1522243800000, "postMarketChangePercent": 2.81284, "postMarketPrice": 1.9226, "postMarketChange": 0.0526, "regularMarketChange": 0.01999998, "regularMarketDayRange": "1.8359 - 1.995", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 202180, "fiftyTwoWeekLowChange": 0.49, "fiftyTwoWeekLowChangePercent": 0.35507247, "fiftyTwoWeekRange": "1.38 - 53.79", "fiftyTwoWeekHighChange": -51.920002, "fiftyTwoWeekHighChangePercent": -0.9652352, "fiftyTwoWeekChangePercent": -93.56061, "earningsTimestamp": 1741690743, "earningsTimestampStart": 1746621000, "earningsTimestampEnd": 1747053000, "isEarningsDateEstimate": true, "displayName": "Q32 Bio", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]